# Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Men

> **NCT01694498** · PHASE2 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 183 (actual)

## Conditions studied

- Nocturia

## Interventions

- **DRUG:** A: Desmopressin 25 µg
- **DRUG:** B. Desmopressin 50 µg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01694498
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2013-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01694498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01694498, "Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Men". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01694498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*